From the *Department of Orthopaedic Surgery, Sports Medicine Division, and †Department of Radiology, Musculoskeletal Division, University of Miami Miller School of Medicine/Jackson Memorial Hospital, Miami, FL.
Received for publication February 2, 2016; accepted March 29, 2016.
Correspondence to: Ty K. Subhawong, MD, Department of Radiology, Musculoskeletal Division, University of Miami Miller School of Medicine/Jackson Memorial Hospital, JMH WW 279, 1611 NW 12th Ave, Miami, FL 33136 (e-mail: [email protected]).
The OAI is a public–private partnership comprised of 5 contracts (N01-AR-2-2258, N01-AR-2-2259, N01-AR-2-2260, N01-AR-2-2261, and N01-AR-2-2262) funded by the National Institutes of Health, a branch of the Department of Health and Human Services, and conducted by the OAI Study Investigators. Private funding partners include Merck Research Laboratories; Novartis Pharmaceuticals Corporation, GlaxoSmithKline; and Pfizer, Inc. Private sector funding for the OAI is managed by the Foundation for the National Institutes of Health. This manuscript was prepared using an OAI public use data set and does not necessarily reflect the opinions or views of the OAI investigators, the NIH, or the private funding partners.”
The authors declare no conflict of interest.
